(Reuters) - British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs made available free-of-charge by AstraZeneca.
The move is the latest example of how the pharmaceutical industry is experimenting with new research models involving greater collaboration with external partners.
The MRC money will pay for work on 15 research projects covering Alzheimer's, cancer and other diseases. Eight will involve clinical trials of potential new drugs and seven will focus on earlier work in laboratory and animal models.
Read more here:
http://www.reuters.com
